Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,320 | 6,280 | 3,320 | 6,920 | 11,320 |
| Marketable Securities | 14,630 | 17,310 | 24,860 | 24,600 | 24,350 |
| Receivables | 80 | 70 | 30 | 40 | 50 |
| Other current assets | 170 | 250 | 430 | 810 | 790 |
| TOTAL | $22,200 | $23,910 | $28,640 | $32,370 | $36,510 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 5,000 | 4,700 | 0 | 5,150 | 5,080 |
| TOTAL | $5,000 | $4,700 | $N/A | $5,150 | $5,080 |
| Total Assets | $27,400 | $28,810 | $33,890 | $37,700 | $41,770 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,750 | 2,640 | 2,290 | 2,370 | 2,840 |
| TOTAL | $2,750 | $2,640 | $2,290 | $2,370 | $2,840 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,750 | $2,640 | $2,290 | $2,370 | $2,840 |
| Shareholders' Equity | |||||
| Common Shares | 92,760 | 86,820 | 92,700 | 92,700 | 92,710 |
| Retained earnings | -83,840 | -75,360 | -76,430 | -72,670 | -68,990 |
| Other shareholders' equity | 5,340 | 5,000 | 6,650 | 6,660 | 6,650 |
| TOTAL | $24,650 | $26,170 | $31,590 | $35,320 | $38,920 |
| Total Liabilities And Equity | $27,400 | $28,810 | $33,880 | $37,690 | $41,760 |